Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 2:55 PM
Study NCT ID:
NCT05804604
Status:
COMPLETED
Last Update Posted:
2023-08-01
First Post:
2023-03-26
Brief Title:
Bone Intake Proteins and Muscle Mass Deficiency in Proximal Femur Fractures
Sponsor:
Medical University of Warsaw
Organization:
Medical University of Warsaw
Study Overview
Official Title:
Serum Concentration of Bone Intake Proteins and Muscle Decay Markers as Risk Factors of Proximal Femur Fractures
Status:
COMPLETED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this clinical trial is to compare serum concentration of bone intake proteins sex hormone-binding globulin SHBG cross linked C-telopeptide of type I collagen CTX-I and muscle atrophy marker creatine kinase CK-MB between patients after the fracture of proximal femur and their age corresponding counterpart without the fracture The main question it aims to answer is
Is the higher concentration of bone intake proteins and muscle atrophy marker a predictive factor of proximal femur fracture
The part of participants Group 1 will be hospitalized at the Department of Orthopaedics and Rehabilitation and will undergo a surgical treatment open reduction of the fracture The rest Group 2 will be admitted to the Department of Internal Medicine Participants of both Groups will have the blood sample test taken to evaluate and compare the serum concentration of SHBG CTX-I and CK-MB proteins
Is the higher concentration of bone intake proteins and muscle atrophy marker a predictive factor of proximal femur fracture
The part of participants Group 1 will be hospitalized at the Department of Orthopaedics and Rehabilitation and will undergo a surgical treatment open reduction of the fracture The rest Group 2 will be admitted to the Department of Internal Medicine Participants of both Groups will have the blood sample test taken to evaluate and compare the serum concentration of SHBG CTX-I and CK-MB proteins
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None